These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24680623)

  • 1. Perceptions of health status and survival in patients with metastatic lung cancer.
    Greer JA; Pirl WF; Jackson VA; Muzikansky A; Lennes IT; Gallagher ER; Prigerson HG; Temel JS
    J Pain Symptom Manage; 2014 Oct; 48(4):548-57. PubMed ID: 24680623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care.
    Pirl WF; Greer JA; Traeger L; Jackson V; Lennes IT; Gallagher ER; Perez-Cruz P; Heist RS; Temel JS
    J Clin Oncol; 2012 Apr; 30(12):1310-5. PubMed ID: 22430269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does awareness of terminal status influence survival and quality of life in terminally ill cancer patients?
    Kim SY; Kim JM; Kim SW; Shin IS; Bae KY; Shim HJ; Hwang JE; Bae WK; Cho SH; Chung IJ; Yoon JS
    Psychooncology; 2013 Oct; 22(10):2206-13. PubMed ID: 23505129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort.
    Jatoi A; Novotny P; Cassivi S; Clark MM; Midthun D; Patten CA; Sloan J; Yang P
    Oncologist; 2007 Dec; 12(12):1456-63. PubMed ID: 18165623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care.
    Temel JS; Greer JA; Admane S; Gallagher ER; Jackson VA; Lynch TJ; Lennes IT; Dahlin CM; Pirl WF
    J Clin Oncol; 2011 Jun; 29(17):2319-26. PubMed ID: 21555700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meaninglessness in terminally ill cancer patients: a validation study and nurse education intervention trial.
    Morita T; Murata H; Hirai K; Tamura K; Kataoka J; Ohnishi H; Akizuki N; Kurihara Y; Akechi T; Uchitomi Y;
    J Pain Symptom Manage; 2007 Aug; 34(2):160-70. PubMed ID: 17544250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of survival in patients with non-small cell lung cancer.
    Luo J; Chen YJ; Narsavage GL; Ducatman A
    Oncol Nurs Forum; 2012 Nov; 39(6):609-16. PubMed ID: 23107855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic Relevance of the Metastatic Localisation in Patients with Stage IV NSCLC - Results of a Prospective Epidemiological Study].
    Blankenburg T; Gottschlich B; Schütte W; Neef H; Haerting J
    Pneumologie; 2010 Nov; 64(11):679-85. PubMed ID: 20577949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
    Belani CP; Brodowicz T; Ciuleanu TE; Krzakowski M; Yang SH; Franke F; Cucevic B; Madhavan J; Santoro A; Ramlau R; Liepa AM; Visseren-Grul C; Peterson P; John WJ; Zielinski CC
    Lancet Oncol; 2012 Mar; 13(3):292-9. PubMed ID: 22336221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and survival prediction in terminal cancer patients: a multicenter study.
    Vigano A; Donaldson N; Higginson IJ; Bruera E; Mahmud S; Suarez-Almazor M
    Cancer; 2004 Sep; 101(5):1090-8. PubMed ID: 15329920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for do-not-resuscitate designation among terminally ill cancer patients receiving care from a palliative care consultation service.
    Kao CY; Wang HM; Tang SC; Huang KG; Jaing TH; Liu CY; Liu KH; Shen WC; Wu JH; Hung YS; Hsu HC; Chen JS; Liau CT; Lin YC; Su PJ; Hsieh CH; Chou WC
    J Pain Symptom Manage; 2014 Feb; 47(2):271-82. PubMed ID: 23856097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale.
    Chuang RB; Hu WY; Chiu TY; Chen CY
    J Pain Symptom Manage; 2004 Aug; 28(2):115-22. PubMed ID: 15276192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
    Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
    Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health state utility scores in advanced non-small cell lung cancer.
    Doyle S; Lloyd A; Walker M
    Lung Cancer; 2008 Dec; 62(3):374-80. PubMed ID: 18467000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
    Langer F; Helsberg K; Schütte WH; Leschinger MI
    Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
    Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
    Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marital status and non-small cell lung cancer survival: the Lung Cancer Database Project in Japan.
    Saito-Nakaya K; Nakaya N; Akechi T; Inagaki M; Asai M; Goto K; Nagai K; Nishiwaki Y; Tsugane S; Fukudo S; Uchitomi Y
    Psychooncology; 2008 Sep; 17(9):869-76. PubMed ID: 18033697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women with lung cancer: quality of life after thoracotomy: a 6-month prospective study.
    Sarna L; Cooley ME; Brown JK; Chernecky C; Padilla G; Danao L; Chakravarty D; Elashoff D
    Cancer Nurs; 2010; 33(2):85-92. PubMed ID: 20142740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitions in Prognostic Awareness Among Terminally Ill Cancer Patients in Their Last 6 Months of Life Examined by Multi-State Markov Modeling.
    Hsiu Chen C; Wen FH; Hou MM; Hsieh CH; Chou WC; Chen JS; Chang WC; Tang ST
    Oncologist; 2017 Sep; 22(9):1135-1142. PubMed ID: 28684551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.